Alere announces cash dividend of $3.

Alere announces cash dividend of $3.00 per share on Series B Convertible Perpetual Preferred Stock Alere Inc. , a global leader in empowering individuals to take greater control of their health at home by linking innovative diagnostics in the hands of sufferers to their healthcare suppliers, has declared a money dividend of $3.00 per share on its Series B Convertible Perpetual Preferred Stock .Outcomes provided in this paper show that the resulting drug-dendrimer formulation releases practically all of its drug within 48 hours in acidic conditions but less than 10 % of its payload at neutral pH. Related StoriesMeat-rich diet may boost kidney cancers riskViralytics enters into scientific trial collaboration agreement with MSDNew RNA test of blood platelets may be used to detect area of cancerWhen examined in cultured colon tumor cells, the researchers found that the drug-dendrimer construct was significantly less toxic than free of charge doxorubicin when they dosed the cells with equivalent levels of doxorubicin.